Antibiotics and the Host-Parasite Relationship in Cystic Fibrosis

  • J. A. Raeburn
  • R. Sutherland
  • R. T. Cullen
  • A. Greening
Conference paper


Patients with cystic fibrosis (CF) have repeated pulmonary infections which lead to chronic bronchiectasis and other forms of lung damage. Although the causative gene has now been located on chromosome 7, and DNA sequences of that gene are being analysed, the reason for the recurrent respiratory infection is not known. Treatment with high doses of appropriate antibiotics, often for several weeks or even on a long-term basis, plays a most important part in management. However, despite newer antibiotics and, in particular, agents with much greater activity against Pseudomonas aeruginosa, many patients with antibiotic-sensitive bacteria in the sputum continue to suffer progressive lung damage.


Cystic Fibrosis Recurrent Respiratory Infection Total Leucocyte Count Lung Damage Chemiluminescence Response 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Auerbach HS, William M et al. (1985) Alternate day prednisolone reduces morbidity and improves lung function in cystic fibrosis. Lancet II:686–688CrossRefGoogle Scholar
  2. 2.
    Cullen RT, McCrae WM, Govan JRW, Raeburn JA (1983) Ceftazidime in cystic fibrosis; clinical, microbiological and immunological studies. J Antimicrob Chemother 12 [Suppl A]:369–375PubMedGoogle Scholar
  3. 3.
    Graft DF, Mischler)E et al. (1982) Granulocyte chemiluminescence in adolescent patients with cystic fibrosis. Amer Rev Respir Dis 125:540–543Google Scholar
  4. 4.
    Kowolik M, Raeburn JA, Grant M (1982) In vivo effect of ampicillin and cefaclor on blood and gingival crevicular neutrophil myeloperoxidase activity. In: Eichenberg H, Opferkuch W (eds) The influence of antibiotics on the host-parasite relationship. Springer, Berlin Heidelberg New York, pp 56–66CrossRefGoogle Scholar
  5. 5.
    McCrae WM, Raeburn JA (1974) Patterns of infection in cystic fibrosis. Scott Med J 19:187–193PubMedGoogle Scholar
  6. 6.
    Pantin CFA, Stead et al. (1986) Presdnisolone in the treatment of airflow obstruction in adults with cystic fibrosis. Thorax 41:34–38PubMedCrossRefGoogle Scholar
  7. 7.
    Raeburn JA, McCrae WM (1976) Immune responses to bacteria in cystic fibrosis. Proceedings of the 7th international congress of cystic fibrosis. Paris, pp 541–544Google Scholar
  8. 8.
    Regelman WE, Lunde NM et al. (1986) Increased monocyte chemilumiscence in cystic fibrosis patients and their parents. Pediatr Res 20:619–622CrossRefGoogle Scholar
  9. 9.
    Wilson GB, Fudenberg HH et al. (1981) Effects of ciliary dyskinesia substances on neutrophil movement in vitro. J Clin Invest 68:171–183PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • J. A. Raeburn
    • 1
  • R. Sutherland
    • 1
  • R. T. Cullen
    • 1
  • A. Greening
    • 1
  1. 1.University Department of MedicineWestern General HospitalEdinburghUK

Personalised recommendations